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Abstract 37 
Bacterial pathogenicity deeply depends on the ability to secrete virulence factors that bind 38 
specific targets on host cells and manipulate host responses. The Gram-positive bacterium 39 
Listeria monocytogenes is a human foodborne pathogen that remains a serious public health 40 
concern. To transport proteins across its cell envelope, this facultative intracellular pathogen 41 
engages a set of specialized secretion systems. Here we show that L. monocytogenes EGDe 42 
uses a specialized secretion system, named ESX-1, to secrete EsxA, a homologue of the 43 
virulence determinants ESAT-6 and EsxA of Mycobacterium tuberculosis and Staphylococcus 44 
aureus, respectively. Our data show that the L. monocytogenes ESX-1 secretion system and its 45 
substrates are dispensable for bacterial invasion and intracellular multiplication in eukaryotic 46 
cell lines. Surprisingly, we found that the EssC-dependent secretion of EsxA has a detrimental 47 
effect on L. monocytogenes in vivo infection. 48 
 49 
Introduction 50 
The capacity to secrete proteins is crucial for the pathogenesis of many bacteria. In Gram-51 
positive bacteria, proteins are delivered by highly specialized secretion systems across cell 52 
envelope to reach specific targets 1. A portion of these proteins, including virulence factors, are 53 
often secreted by Sec-independent systems. ESX-1, also called WXG100, is a Sec-independent 54 
secretion system first described in Mycobacterium tuberculosis 2-4. This system allows the 55 
secretion of ≈100 amino-acid-long proteins that lack the classical signal peptide but contain a 56 
Trp-X-Gly motif (WXG100 proteins). M. tuberculosis ESAT-6 and CFP-10 are prototypes of 57 
WXG100 proteins, both encoded by the region of difference 1 (RD1), involved in virulence 58 
and described as highly immunogenic proteins 5. Deletion of the esx-1 locus abrogates ESX-1-59 
dependent secretion and strongly attenuates the virulence of M. tuberculosis 6. Apart from 60 
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mycobacterial species, ESX-1 systems are also found in Firmicutes, among which the S. 61 
aureus ESX-1 is one of the best-characterized 7, 8. It comprises genes encoding the canonical 62 
ESX-1 substrates (EsxA, EsxB), a membrane-anchored FtsK/SpoIIIE-like ATPase (EssC) 63 
essential for the secretion machinery, genes coding for membrane-embedded proteins (EssA, 64 
EssB, EssD) required for secretion of ESX-1 substrates, as well as staphylococci-specific ESX-65 
1 substrates (EsxC, EsxD), and modulators of ESX-1 activity (EsaA, EsaB) 7-10. S. aureus 66 
EsxA and EsxB share features with the M. tuberculosis ESAT-6 and CFP-10, including the 67 
presence of a WXG motif and the co-dependent secretion. However, unlike ESAT-6 and CFP-68 
10, EsxA and EsxB do not interact. EsxA dimerizes with itself or associates with EsxC, while 69 
EsxB interacts with EsxD 8. Disruption of key components of the S. aureus ESX-1 secretion 70 
machinery (EssC) or deletion of esxA and esxB causes a significant reduction in the ability of S. 71 
aureus to establish kidney or liver abscesses 7 , 9, 11. Moreover, the S. aureus ESX-1 secretion 72 
system is required for nasal colonization and virulence in a murine lung pneumonia model 12. 73 
EsxA was also shown to interfere with host cell apoptotic pathways, affecting bacterial survival 74 
and mediating S. aureus release from host cells 13. Other ESX-1 substrates, such as EsaC, 75 
although dispensable for the establishment of acute infections, are required for the formation of 76 
persistent infection 11. Functional ESX-1 secretion systems were also characterized in Bacillus 77 
anthracis, Bacillus subtilis, Actinobacterium and Streptomyces coelicolor 14-17. 78 
Listeria monocytogenes (Lm) is a ubiquitous Gram-positive bacterium responsible for 79 
listeriosis, a severe opportunistic foodborne disease occurring mainly in immunocompromised 80 
individuals, newborn, elderly and pregnant women. Listeriosis is the most frequent cause of 81 
hospitalization and death due to the consumption of contaminated food in Europe, and involves 82 
high illness costs and quality life losses 18. Clinical features of listeriosis includes septicemia, 83 
meningitis, meningoencephalitis and abortions. This facultative intracellular pathogen has 84 
evolved multiple strategies to survive inside phagocytic cells, invade non-phagocytic cells and 85 
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spread from cell to cell 19. Each step of its cell infection cycle depends on specific virulence 86 
determinants that play specific roles, most of them being surface or secreted proteins 20, 21. 87 
Genes encoding a potential ESX-1 secretion system were identified in Lm 22 and the Lm EsxA 88 
homologue was previously shown dispensable for Lm mouse infection 23. However, although 89 
ESX-1 was postulated to represent a broad Gram-positive secretion system 1, the functionality 90 
of this apparatus and its role in infection were never previously investigated in Listeria. 91 
 92 
Results 93 
Lm encodes a putative ESX-1 secretion system. 94 
In agreement with the model proposed for the ESX-1 secretory apparatus 1, 22 and following 95 
bioinformatic analyses (BLAST, TopPred2, ProDom) we determined that the Lm ESX-1 locus 96 
contains genes coding for: the two canonical WXG100 substrate paralogs EsxA (Lmo0056) 97 
and EsxB (Lmo0063), the integral membrane FtsK/SpoIIIE-type ATPase EssC (Lmo0061);  98 
EsaA (Lmo0057), a polytopic membrane protein with five predicted transmembrane helices; 99 
EssA (Lmo0058) and EssB (Lmo0060), two predicted membrane proteins with respectively 100 
one and two transmembrane domains; and EsaB (Lmo0059) and Lmo0062, two putative 101 
cytoplasmic proteins (Fig. 1A). Membrane topology or soluble character of proteins encoded 102 
by the Lm ESX-1 locus was predicted and compared to M. tuberculosis and S. aureus ESX-1 103 
secretion systems (Fig. 1B). This revealed large similarities with the S. aureus ESX-1 systems. 104 
However, the two ESX-1 substrates (EsxC and EsxD) and the EssD transmembrane protein 105 
described in S. aureus are absent in Lm. Analysis of complete genome sequences available for 106 
different Listeria species revealed the high level of conservation of the ESX-1 locus within the 107 
Listeria genus (Fig. 1A). Of note, esxB and lmo0062 are absent from three non-pathogenic 108 
species (L. welshimeri, L. seeligeri and L. grayi). 109 
 110 
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Lm ESX-1 secretion system is functional although weakly expressed. 111 
To evaluate the expression of the Lm esx-1 locus, we analyzed by RT-PCR the transcription of 112 
genes encoding the two major ESX-1 effectors (esxA and esxB), and two integral membrane 113 
proteins essential for the secretion machinery (essB and essC) 7-10. RNAs extracted from 114 
bacteria in exponential growth phase in BHI at 37ºC were processed for analysis and results 115 
showed that all the genes selected are transcribed in these conditions (Fig. 2A). However, esxB, 116 
essC and essB appeared to be weakly expressed as compared to esxA and control genes (inlA, 117 
actA, iap) encoding known Lm virulence factors. We also observed that the expression of esxA 118 
appeared to decrease upon entry into stationary growth phase, which was confirmed by qRT-119 
PCR (Fig. 2B). We also attempted to assess by qRT-PCR the expression of esxB and essC 120 
during growth in exponential or stationary phases. However, transcript levels appeared 121 
insufficient to obtain quantifiable amplification, in particular during the stationary growth 122 
phase, thus underlining the weak level of expression of these genes. esxA was previously 123 
shown to be negatively regulated by SigB in S. aureus 24. SigB being the major regulator of the 124 
stationary growth phase, we assessed if the decreased expression of esxA upon entry into this 125 
phase would be due to SigB regulation. We analyzed by qRT-PCR the expression of esxA in a 126 
sigB deletion mutant as compared to the WT strain during growth in exponential and stationary 127 
phases, and showed that in both growth phases esxA expression appeared independent of the 128 
presence of sigB (Fig. 2C). bsh, which encodes a bile salt hydrolase, was used as a SigB-129 
dependent control gene 25. 130 
To analyse whether the putative Lm ESX-1 system was functional, we constructed a deletion 131 
mutant strain for essC (ΔessC), which encodes a structural protein essential for S. aureus ESX-132 
1 functionality 7, as well as the corresponding complemented strain (ΔessC+essC). Both strains 133 
were confirmed by PCR and sequencing, and their growth rate in BHI at 37ºC was comparable 134 
to that of the WT (Fig. S1A-B). To test the functionality of the ESX-1 secretion system in Lm, 135 
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we expressed a myc-tagged EsxA protein (EsxA-myc) in WT bacteria and analyzed its 136 
secretion during bacterial growth. Western blot of bacterial culture supernatants showed a band 137 
of 11 kDa, the expected size for EsxA-myc, with a higher intensity in the exponential growth 138 
phase (Fig. 2D left panel). These results indicate that Lm EsxA was secreted in these 139 
conditions. We then expressed EsxA-myc in the ΔessC and ΔessC+essC strains and performed 140 
the same western blot analysis on proteins from the WT, WT+esxA-myc, ΔessC, ΔessC+esxA-141 
myc and ΔessC+essC+esxA-myc total bacterial lysates and culture supernatants in exponential 142 
growth phase. In the WT+esxA-myc strain, EsxA-myc was detected both in the total lysates and 143 
culture supernatants, indicating that the protein is produced and secreted (Fig. 2D right panel). 144 
In the ΔessC+esxA-myc strain, EsxA-myc was absent from the supernatant and retained in total 145 
lysates, demonstrating that EsxA is secreted in an EssC-dependent manner. This was 146 
confirmed by the complementation of the ΔessC+esxA-myc mutant that restored the secretion 147 
of EsxA-myc (ΔessC+essC+esxA-myc line). Altogether, these results show that Lm expresses a 148 
functional ESX-1 secretion system, albeit at low levels, and that EsxA secretion requires the 149 
putative membrane ATPase EssC. 150 
 151 
Lm ESX-1 is dispensable for host cell invasion and intracellular multiplication. 152 
To investigate the role of the ESX-1 system in Lm cell invasion and intracellular 153 
multiplication, we constructed deletion mutants for esxA, that we showed to encode a substrate 154 
of Lm ESX-1, and esxB that encodes another putative ESX-1 substrate 7. Mutants were 155 
confirmed by PCR and sequencing, and their growth rates observed in BHI at 37ºC were 156 
comparable to that of the WT (Fig. S1A-B). 157 
The WT, ΔesxA, ΔesxB and ΔessC strains were tested for their capacity to invade epithelial cell 158 
lines in which Lm entry is mainly mediated by internalin A (InlA) (Caco-2) or InlB (Vero). No 159 
significant difference in invasion was observed between mutant and WT bacteria in both cell 160 
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lines (Fig. 3A), suggesting that the ESX-1 system is not required for Lm invasion of epithelial 161 
cells. 162 
To analyse the role of ESX-1 in Lm intracellular multiplication, the behaviour of the WT, 163 
ΔesxA, ΔesxB and ΔessC strains was studied after internalization in J774 murine macrophage-164 
like cells. All strains grew with similar multiplication rates after uptake (Fig. 3B), indicating 165 
that none of these genes is required for Lm intracellular replication in macrophage-like cells. 166 
Altogether these results indicate that the ESX-1 secretion system is dispensable for Lm cell 167 
invasion and intracellular multiplication. 168 
 169 
ESX-1 activity impairs Lm infection. 170 
To analyse the involvement of the ESX-1 system in Lm infection in vivo, we monitored the 171 
number of bacteria in the liver and spleen of mice infected intravenously with ΔesxA, ΔesxB, 172 
ΔessC or WT bacteria. Unexpectedly, 72h post-infection, all the mutant strains showed a slight 173 
increase in bacterial counts in both organs as compared to WT, which was statistically 174 
significant for ΔesxB (Fig. 4A), implying that ESX-1 activity might have a negative impact on 175 
Lm infection. 176 
To investigate the potential role of ESX-1 in the gastrointestinal phase of the infectious 177 
process, we performed oral inoculation of mice with the WT, ΔesxA, ΔesxB and ΔessC strains. 178 
Three days post-inoculation, mutant strains appeared again to be slightly more virulent than the 179 
WT. This increased infection was statistically significant for ΔesxA in mouse livers (Fig. 4B). 180 
These data indicate that neither the ESX-1 apparatus nor its substrates are crucial for Lm 181 
infection in the mouse model. Conversely, they suggest that the expression/function of this 182 
secretion system causes an adverse effect in Lm pathogenicity. 183 
 184 
 185 
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Overexpression of esxA in the context of a functional ESX-1 system is detrimental to Lm 186 
infection. 187 
To further investigate if the ESX-1 function could have a negative effect on Lm infection, we 188 
performed intravenous infection of mice with Lm overexpressing esxA (+esxA), together with 189 
the WT and ΔesxA strains. The esxA overexpression in the +esxA strain was first confirmed by 190 
qRT-PCR (Fig. S2A). Growth rate of the +esxA strain in BHI or minimal medium at 37ºC, as 191 
well as its cell adhesion and infection capacity were comparable to that of the WT strain (Fig. 192 
S2B-C), indicating that esxA overexpression has no significant impact on Lm growth and 193 
cellular infectious properties. Three days post infection the ΔesxA mutant appeared slightly 194 
more virulent as compared to the WT, as already observed (Fig. 4A), whereas +esxA bacteria 195 
showed a significant number decrease in both mouse organs (Fig. 5A). Inversely, esxA 196 
overexpression had no effect on the phenotype of a ΔessC mutant that, similarly to the ΔesxA 197 
mutant, also appeared to colonize more efficiently mouse organs than the WT strain (Fig. 5B). 198 
These results demonstrate that the detrimental effect of ESX-1 on Lm pathogenicity is due to 199 
EsxA secretion and depends on a functional ESX-1 machinery. 200 
The production of IFN-γ and TNF-α by immune cells promotes bacterial clearance and is 201 
critical in controlling primary L. monocytogenes infections 26. To investigate if the adverse 202 
effect of esxA overexpression on Lm infection is related with higher levels of host IFN-γ and/or 203 
TNF-α, we analysed by qRT-PCR levels of IFN-γ and TNF-α transcripts in the liver of WT or 204 
+esxA-infected mice. No significant difference was observed regarding expression levels of 205 
IFN-γ and TNF-α (Fig. 5C). In addition, to discard any role of IFN-γ in the increased resistance 206 
of mice to esxA overexpressing Lm, WT and IFN-γ knock-out mice (IFN-γ-/-) were 207 
intravenously infected with WT or +esxA bacteria. Three days post-infection, bacterial loads 208 
were overall higher in the organs of IFN-γ-/- than in WT mice (Fig. 5D). These data indicated 209 
that IFN-γ deficient mice are more susceptible to Lm infection and confirmed the role of IFN-γ 210 
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in the immune response against Lm 27. In line with data observed in BALB/c mice (Fig. 5A), 211 
the +esxA strain showed significant infection attenuation in both organs of WT mice as 212 
compared to Lm WT bacteria (Fig. 5D). However, this infection defect was similar in IFN-γ 213 
deficient animals, suggesting that IFN-γ is not involved in the increased resistance of mice to 214 
Lm overexpressing esxA. 215 
 216 
Discussion 217 
The analysis of the bacterial ability to secrete proteins to or beyond their surface is crucial in 218 
the understanding of bacterial pathogenesis. In M. tuberculosis and S. aureus, ESX-1 and its 219 
substrates were shown to play an important role in virulence 5, 7. ESX-1 appears to be very 220 
conserved in Listeria, in particular among pathogenic species, and only partially present in the 221 
majority of non-pathogenic Listeria species. 222 
We showed that the ESX-1 locus of L. monocytogenes EGDe is expressed in standard growth 223 
conditions, with esxA appearing more expressed than esxB, essB and essC. These results are in 224 
agreement with previous transcriptional analyses 28 and are consistent with the presence of a 225 
transcription terminator between esxA and esaA. This could suggest a different transcriptional 226 
regulation between esxA and the other ESX-1 genes. Regarding the expression of ESX-1 genes 227 
in different conditions, no change were observed when bacteria were grown at 37ºC, 25ºC or 228 
7ºC 29, 30, nor in presence of 6% NaCl 29, nor when grown at pH5 31, nor when grown in culture 229 
media supplemented with glucose, cellobiose or glycerol 32, 33.  In addition, as compared to 230 
bacteria grown in BHI at 37ºC, the expression of the ESX-1 locus appears also unchanged in 231 
Listeria recovered from infected murine macrophages 34, 35, or from mouse intestinal lumen 36 232 
and spleens 37. Interestingly, the entire ESX-1 locus was shown as up-regulated after 233 
incubation of Lm in human blood 36, and essC and esxC were also shown as up-regulated 234 
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during cell infection 34. Altogether, these results indicate that the ESX-1 locus of L. 235 
monocytogenes EGDe is poorly or not expressed in most of the conditions, with some genes of 236 
the locus expressed in few conditions that could suggest a role of the ESX-1 apparatus in these 237 
specific environments. 238 
Using a deletion mutant and complemented strain for essC, we demonstrated that ESX-1 is 239 
functional in Lm, at least for the secretion of EsxA. Even if EssC was shown to be an essential 240 
ESX-1 element also for the secretion of EsxB in M. tuberculosis and S. aureus 5, 7, the EssC-241 
dependent secretion of EsxB remains to be confirmed in Lm. EsxA and EsxB are the only 242 
WXG100 proteins predicted to be encoded by the Lm genome. In addition to EsxA and EsxB, 243 
the EsxC protein is also a substrate for ESX-1 in S. aureus and confers pathogenic function to 244 
this bacterium 11. However, an esxC ortholog is absent from Lm. Instead, an unrelated gene of 245 
unknown function (lmo0062) occupies the esxC position in the Lm genome (Fig. 1). 246 
Interestingly, Lmo0062 was recently predicted to be secreted 38, therefore investigating its 247 
capacity to be secreted in an ESX-1-dependent manner could widen the spectrum of ESX-1 248 
substrates to proteins that do not belong to the WXG100 family.  249 
All the above observations induced a strong presumption for the involvement of ESX-1 in Lm 250 
pathogenicity. However, we demonstrated that this secretion system and its substrates are not 251 
required for Lm cell invasion, intracellular multiplication and in vivo infection. In agreement 252 
with our results, EsxA was also previously shown dispensable for Lm mouse infection 23. 253 
Unexpectedly, we observed a slight increase in the infection level of mutants for ESX-1 254 
components as compared to WT bacteria. This was also previously observed for a ΔesxA 255 
mutant 23, suggesting a damaging role for ESX-1 in Listeria infectious capacity. In agreement 256 
with this hypothesis, overexpression of esxA resulted in a decrease infection of Lm in the 257 
mouse model, confirming the adverse effect of a functional ESX-1 secretion system. Despite 258 
our attempts to elucidate the reasons of this detrimental role, we failed to find differences 259 
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regarding host immune responses upon infection by WT or esxA overexpressing Lm. ESAT-6 260 
(the mycobacterial EsxA homolog) was shown to play a pro-apoptotic role in M. tuberculosis 261 
39. A comparable role of Lm EsxA could result in increased bacterial recognition and clearance 262 
by the host immune system that would explain the phenotype of esxA overexpressing bacteria. 263 
The absence of EssC in the bacterial membrane could also disturb cell envelope homeostasis, 264 
possibly resulting in the mislocalization of some surface proteins that could induce an 265 
increased virulence. However, no difference was observed regarding the capacity of mutants 266 
for ESX-1 components to invade or multiply inside host cells as compared to WT Lm. 267 
L. monocytogenes is sensitive to a broad range of antibiotics. However, resistance to several 268 
antibiotics has been reported 40, as well as multidrug-resistant strains 41. The ESX-1 system 269 
could appear as a potential target for innovative anti-Listeria drugs that, by inducing ESX-1-270 
dependent secretion, would be capable to impair the infectious capacity of bacteria but not their 271 
viability, significantly reducing the risk of resistance development. 272 
Listeria has maintained this locus in its genome, suggesting that it may probably be helpful in 273 
certain conditions, such as resisting to stress encountered in specific environments. However, 274 
we were unable to find any difference between the WT and essC mutant regarding growth in 275 
stress conditions such as low pH (pH 5.5) and high salt concentration (4.5% NaCl) (Fig. S1C). 276 
Another reason for the conservation of this locus in the Listeria genome could be related to a 277 
strain issue. Indeed, we tested here the role of the ESX-1 system in only one specific Lm strain 278 
(L. monocytogenes EGDe), that is one of the most commonly used laboratory strains 42, 43. 279 
Even if EsxA was also shown to be dispensable for in vitro and in vivo growth of a different 280 
widely used Lm strain 23, 43, this locus could play important roles in the infection capacity of 281 
other Listeria strains from different serotypes. 282 
In summary, we demonstrated here that the Lm genome encodes a functional ESX-1 secretion 283 
system required for the secretion of WXG100 proteins, such as EsxA. In addition, despite 284 
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poorly expressed and dispensable for cell invasion, we showed that a working ESX-1 system is 285 
detrimental for Lm infection in vivo. Considering its wide distribution among Gram-positive 286 
bacteria and the lack of a convergent phenotypic trait for mutants in this pathway, ESX-1 287 
certainly fulfils different functions that remain to be elucidated. 288 
 289 
 290 
Materials and methods 291 
 292 
Bacterial strains and media. 293 
Lm EGDe (ATCC-BAA-679) and E. coli strains were routinely cultured aerobically at 37 ºC in 294 
brain heart infusion (BHI, Difco) and Lysogeny Broth (LB) media, respectively, with shaking.  295 
The synthetic minimal medium (MM) was prepared as previously described 44. When 296 
appropriate, the following antibiotics were included in culture media as selective agents: 297 
ampicilin (Amp), 100 μg/ml; chloramphenicol (Cm), 7 μg/ml (Lm) or 20 μg/ml (E. coli); 298 
erythromycin (Ery), 5 μg/ml. For genetic complementation purposes, colistin sulfate (Col) and 299 
nalidixic acid (Nax) were used at 10 and 50 μg/ml, respectively. 300 
Construction and complementation of mutant strains. 301 
lmo0056, lmo0061 and lmo0063 deletions were performed in the EGD-e background through a 302 
process of double homologous recombination mediated by the suicide plasmid pMAD as 303 
described 45 using the corresponding oligonucleotides (A-D; Table S1). Genetic 304 
complementation of the deletion mutant strains was performed using the phage-derived 305 
integrative plasmid pPL2 as described 45 using the respective oligonucleotides (Table-S1). For 306 
overexpression, target genes were cloned into the pRB474 vector as described 46. All plasmid 307 
constructs and strains were confirmed by PCR and DNA sequencing. 308 
 309 
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Western blot analysis of EsxA. 310 
Overnight bacterial cultures grown in static conditions (final OD660 ~1.0) were centrifuged (10 311 
000 g, 10 min, 4ºC) and the supernatant filtered using Millipore 0.45 µm filters. A volume of 312 
1.6 ml of 50% trichloroacetic acid was added to 6 ml of the filtered supernatant and incubated 313 
for 1 h at 4ºC. The sample was centrifuged (30 000 g, 20 min, 4ºC) and the pellet washed with 314 
cold acetone, repeating the centrifugation step in same conditions. The pellet was dried, 315 
suspended in 30 µl of PBS pH 7.4 and mixed with 15 µl of 4x Laemmli buffer. A volume of 15 316 
µl was loaded in a 12% SDS-polyacrylamide gel. For total bacterial lysates, the bacterial pellet 317 
from 10 ml of culture was suspended in 0.8 ml of PBS pH 7.4 containing 100 µg/ml DNase 318 
and protease inhibitors. Bacteria were lysed in a FastPrep-24 homogenizer (MP Biomedicals) 319 
(30 s, maximum speed) and cell debris removed by centrifugation (3 000 g, 5 min, 4ºC). A 320 
volume of 40 µl of 4x Laemmli buffer was added to 100 µl of supernatant of bacterial lysates, 321 
and 10 µl loaded into the gels. Western blotting was performed as described 46 using anti-Myc 322 
tag mouse antibody (#clone 9B11, Cell Signalling #2276). 323 
Gene expression analyses. 324 
Bacterial RNAs were isolated from 10 ml of cultures at the desired growth phase. For 325 
quantification of cytokine expression in mouse livers, organs were homogenized in RNAlater 326 
stabilization solution (Qiagen), quick-frozen in dry ice and stored at -80ºC. Total RNAs were 327 
extracted by the phenol-chloroform method as previously described 47, and treated with DNase 328 
I (Turbo DNA-free, Ambion) as recommended by the manufacturer. Purified RNAs (1 μg) 329 
were reverse-transcribed with random hexamers, using iScript cDNA Synthesis kit (Bio-Rad 330 
Laboratories). For qualitative analysis, PCR was performed in 20-μl reactions containing 2 μl 331 
of cDNA, 10 μl of MangoMix 2× reaction mix (Bioline) and 0.5 μM of forward and reverse 332 
primers (Table S1), using the following protocol: 1 cycle at 95 ºC (5 min), 25 cycles at 95 ºC 333 
(30 s), 55 ºC (30 s) and 72 ºC (20 s), and 1 cycle at 72 ºC (5 min). Amplification products were 334 
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resolved in 1% (w/v) agarose gel and analyzed in a GelDoc XR+ System (Bio-Rad 335 
Laboratories). Quantitative real-time PCR (qRT-PCR) was performed in 20-μl reactions 336 
containing 2 μl of cDNA, 10 μl of SYBR Green Supermix (Bio-Rad Laboratories) and 337 
0.25 μM of forward and reverse primers (Table S1), using the following cycling protocol: 338 
1 cycle at 95 ºC (3 min) and 40 cycles at 95 ºC (30 s), 55 ºC (30 s) and 72 ºC (30 s). Each target 339 
gene was analysed in triplicate and blank (water) and DNA contamination controls 340 
(unconverted DNase I-treated RNA) were included for each primer pair. Amplification data 341 
were analysed by the comparative threshold (ΔΔCt) method, after normalization of the test and 342 
control sample expression values to a housekeeping reference gene (16S rRNA).  343 
Adhesion and invasion assays. 344 
Adhesion and invasion assays were performed as described 45. Briefly, Caco-2 (ATCC, HTB-345 
37) and Vero (ATCC, CCL-81) cells were seeded (in triplicate) per 24-well plates 346 
(~2×105/well) in EMEM 20% foetal bovine serum and DMEM 10% foetal bovine serum, 347 
respectively (LONZA), and propagated for 48 h. Listeria were grown in BHI to OD600nm=0.8, 348 
washed and inoculated at 50 bacteria-per-cell for 1h. For adhesion, cells were washed three 349 
times washed, lysed in 0.2% Triton X-100 and viable bacteria were enumerated after plating 350 
serial dilutions of the lysates in BHI agar media. For invasion assays, cells were infected for 1h 351 
and treated with 20 μg/ml gentamicin for 1h30 before lysis in 0.2% Triton X-100.  352 
Intracellular multiplication. 353 
Mouse macrophage-like J774A.1 cells (ATCC TIB-67) were propagated in Dulbecco’s 354 
modified Eagle’s medium (DMEM) containing 10% fetal bovine serum and infection assays 355 
were performed as described 37. Briefly, cells (~2×105/well) were infected for 45 min with 356 
exponential-phase bacteria at ~10 bacteria/cell and treated afterwards with 20 μg/ml 357 
gentamicin for 75 min. At several time-points post-infection, cells were washed with PBS and 358 
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lysed in cold 0.2% Triton X-100 for quantification of viable intracellular bacteria in BHI agar. 359 
One experiment was performed with triplicates for each strain and time-point. 360 
Animal infections. 361 
Infections were performed in six-to-eight week-old specific-pathogen-free females as described 362 
48. Briefly, wild-type BALB/c (Charles River Laboratories) or wild-type IFN-γ knock-out 363 
C57BL/6J mice were infected intravenously with 104 CFUs in PBS, or starved 12h before 364 
gavage inoculation with 109 CFUs in PBS containing 150 mg/ml CaCO3. The infection was 365 
carried out for 72 h, at which point the animals were euthanized by general anesthesia. The 366 
spleen and liver were aseptically collected, homogenized in sterile PBS, and serial dilutions of 367 
the organ homogenates plated in BHI agar. Mice were maintained at the IBMC animal 368 
facilities, in high efficiency particulate air (HEPA) filter-bearing cages under 12-h light cycles, 369 
and were given sterile chow and autoclaved water ad libitum. 370 
Ethics Statement. 371 
All the animal procedures were in agreement with the guidelines of the European Commission 372 
for the handling of laboratory animals (directive 2010/63/EU), with the Portuguese legislation 373 
for the use of animals for scientific purposes (Decreto-Lei 113/2013), and were approved by 374 
the IBMC Animal Ethics Committee, as well as by the Direcção Geral de Veterinária, the 375 
Portuguese authority for animal protection, under license PTDC/SAU-MIC/111581/2009. 376 
Statistical analyses. 377 
Statistical analyses were performed with Prism 6 (GraphPad Software). Unpaired two-tailed 378 
Student’s t-test was used to compare the means of two groups; one-way ANOVA was used 379 
with Tukey’s post-hoc test for pairwise comparison of means from more than two groups, or 380 
with Dunnett’s post-hoc test for comparison of means relative to the mean of a control group. 381 
Mean differences were considered statistically non-significant (ns) when p value was above 382 
0.05. For statistically significant differences: *, p≤0.05; **, p≤0.01; ***, p≤0.001. 383 
  Pinheiro et al 
 
 
 
16
Acknowledgment: 384 
We thank Rui Appelberg for PhD co-supervision of O.R., J.P. and F.C. and MT.A. We thank 385 
S. Lamas (Animal Facility), and P. Magalhaes (CCGEN) from IBMC facilities for technical 386 
assistance. This work was supported for the D.C. lab by national funds through FCT - 387 
Fundação para a Ciência e a Tecnologia/MEC - Ministério da Educação e Ciência and co-388 
funded by FEDER funds within the partnership agreement PT2020 related with the research 389 
unit number 4293, and within the research project Infect-ERA/0001/2013 PROANTILIS. O.R., 390 
J.P. and F.C. were supported by doctoral fellowships from FCT (SFRH/BD/28185/2006, 391 
SFRH/BD/86871/2012 and SFRH/BD/61825/2009), L.M. by the Santander International 392 
Mobility Program and SS by FCT Investigator program (COMPETE, POPH, and FCT). This 393 
work was supported for the F.G.-dP. lab by grants BIO2014-55238-R (to M.G.P.) and 394 
BIO2013-46281-P (to F.G.-dP.) from the Spanish Ministry of Economy and Competitiveness.395 
  Pinheiro et al 
 
 
 
17
References 396 
1. Schneewind O, Missiakas DM. Protein secretion and surface display in Gram-positive 397 
bacteria. Philos Trans R Soc Lond B Biol Sci 2012; 367:1123-39. 398 
2. Simeone R, Bottai D, Frigui W, Majlessi L, Brosch R. ESX/type VII secretion systems of 399 
mycobacteria: Insights into evolution, pathogenicity and protection. Tuberculosis 2015; 95 400 
Suppl 1:S150-4. 401 
3. Houben EN, Korotkov KV, Bitter W. Take five - Type VII secretion systems of 402 
Mycobacteria. Biochim Biophys Acta 2014; 1843:1707-16. 403 
4. Bottai D, Groschel MI, Brosch R. Type VII Secretion Systems in Gram-Positive Bacteria. 404 
Curr Top Microbiol Immunol 2016. 405 
5. Stanley SA, Raghavan S, Hwang WW, Cox JS. Acute infection and macrophage 406 
subversion by Mycobacterium tuberculosis require a specialized secretion system. Proc Natl 407 
Acad Sci U S A 2003; 100:13001-6. 408 
6. Lewis KN, Liao R, Guinn KM, Hickey MJ, Smith S, Behr MA, et al. Deletion of RD1 409 
from Mycobacterium tuberculosis mimics bacille Calmette-Guerin attenuation. J Infect Dis 410 
2003; 187:117-23. 411 
7. Burts ML, Williams WA, DeBord K, Missiakas DM. EsxA and EsxB are secreted by an 412 
ESAT-6-like system that is required for the pathogenesis of Staphylococcus aureus infections. 413 
Proc Natl Acad Sci U S A 2005; 102:1169-74. 414 
8. Anderson M, Aly KA, Chen YH, Missiakas D. Secretion of atypical protein substrates by 415 
the ESAT-6 secretion system of Staphylococcus aureus. Mol Microbiol 2013; 90:734-43. 416 
9. Anderson M, Chen YH, Butler EK, Missiakas DM. EsaD, a secretion factor for the Ess 417 
pathway in Staphylococcus aureus. J Bacteriol 2011; 193:1583-9. 418 
10. Chen YH, Anderson M, Hendrickx AP, Missiakas D. Characterization of EssB, a protein 419 
required for secretion of ESAT-6 like proteins in Staphylococcus aureus. BMC Microbiol 420 
2012; 12:219. 421 
11. Burts ML, DeDent AC, Missiakas DM. EsaC substrate for the ESAT-6 secretion pathway 422 
and its role in persistent infections of Staphylococcus aureus. Mol Microbiol 2008; 69:736-46. 423 
12. Kneuper H, Cao ZP, Twomey KB, Zoltner M, Jager F, Cargill JS, et al. Heterogeneity in 424 
ess transcriptional organization and variable contribution of the Ess/Type VII protein secretion 425 
system to virulence across closely related Staphylocccus aureus strains. Mol Microbiol 2014; 426 
93:928-43. 427 
13. Korea CG, Balsamo G, Pezzicoli A, Merakou C, Tavarini S, Bagnoli F, et al. 428 
Staphylococcal Esx proteins modulate apoptosis and release of intracellular Staphylococcus 429 
aureus during infection in epithelial cells. Infect Immun 2014; 82:4144-53. 430 
14. Garufi G, Butler E, Missiakas D. ESAT-6-like protein secretion in Bacillus anthracis. J 431 
Bacteriol 2008; 190:7004-11. 432 
15. Akpe San Roman S, Facey PD, Fernandez-Martinez L, Rodriguez C, Vallin C, Del Sol R, 433 
et al. A heterodimer of EsxA and EsxB is involved in sporulation and is secreted by a type VII 434 
secretion system in Streptomyces coelicolor. Microbiology 2010; 156:1719-29. 435 
16. Baptista C, Barreto HC, Sao-Jose C. High levels of DegU-P activate an Esat-6-like 436 
secretion system in Bacillus subtilis. PLoS One 2013; 8:e67840. 437 
17. Huppert LA, Ramsdell TL, Chase MR, Sarracino DA, Fortune SM, Burton BM. The ESX 438 
system in Bacillus subtilis mediates protein secretion. PLoS One 2014; 9:e96267. 439 
  Pinheiro et al 
 
 
 
18
18. European Food Safety Authority ECfDPaC. The European Union summary report on 440 
trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2013. European 441 
Food Safety Authority, European Centre for Disease Prevention and Control EFSA Journal 442 
2015; 13:3991. 443 
19. Cossart P. Illuminating the landscape of host-pathogen interactions with the bacterium 444 
Listeria monocytogenes. Proc Natl Acad Sci U S A 2011; 108:19484-91. 445 
20. Camejo A, Carvalho F, Reis O, Leitao E, Sousa S, Cabanes D. The arsenal of virulence 446 
factors deployed by Listeria monocytogenes to promote its cell infection cycle. Virulence 447 
2011; 2:379-94. 448 
21. Carvalho F, Sousa S, Cabanes D. How Listeria monocytogenes organizes its surface for 449 
virulence. Frontiers in cellular and infection microbiology 2014; 4:48. 450 
22. Desvaux M, Hebraud M. The protein secretion systems in Listeria: inside out bacterial 451 
virulence. FEMS Microbiol Rev 2006; 30:774-805. 452 
23. Way SS, Wilson CB. The Mycobacterium tuberculosis ESAT-6 homologue in Listeria 453 
monocytogenes is dispensable for growth in vitro and in vivo. Infect Immun 2005; 73:6151-3. 454 
24. Schulthess B, Bloes DA, Berger-Bachi B. Opposing roles of sigmaB and sigmaB-455 
controlled SpoVG in the global regulation of esxA in Staphylococcus aureus. BMC Microbiol 456 
2012; 12:17. 457 
25. Zhang Q, Feng Y, Deng L, Feng F, Wang L, Zhou Q, et al. SigB plays a major role in 458 
Listeria monocytogenes tolerance to bile stress. Int J Food Microbiol 2011; 145:238-43. 459 
26. Stavru F, Archambaud C, Cossart P. Cell biology and immunology of Listeria 460 
monocytogenes infections: novel insights. Immunol Rev 2011; 240:160-84. 461 
27. Harty JT, Bevan MJ. Specific immunity to Listeria monocytogenes in the absence of IFN 462 
gamma. Immunity 1995; 3:109-17. 463 
28. Wurtzel O, Sesto N, Mellin JR, Karunker I, Edelheit S, Becavin C, et al. Comparative 464 
transcriptomics of pathogenic and non-pathogenic Listeria species. Mol Syst Biol 2012; 8:583. 465 
29. Bergholz TM, Bowen B, Wiedmann M, Boor KJ. Listeria monocytogenes shows 466 
temperature-dependent and -independent responses to salt stress, including responses that 467 
induce cross-protection against other stresses. Appl Environ Microbiol 2012; 78:2602-12. 468 
30. Garmyn D, Augagneur Y, Gal L, Vivant AL, Piveteau P. Listeria monocytogenes 469 
differential transcriptome analysis reveals temperature-dependent Agr regulation and suggests 470 
overlaps with other regulons. PLoS One 2012; 7:e43154. 471 
31. Neuhaus K, Satorhelyi P, Schauer K, Scherer S, Fuchs TM. Acid shock of Listeria 472 
monocytogenes at low environmental temperatures induces prfA, epithelial cell invasion, and 473 
lethality towards Caenorhabditis elegans. BMC Genomics 2013; 14:285. 474 
32. Marr AK, Joseph B, Mertins S, Ecke R, Muller-Altrock S, Goebel W. Overexpression of 475 
PrfA leads to growth inhibition of Listeria monocytogenes in glucose-containing culture media 476 
by interfering with glucose uptake. J Bacteriol 2006; 188:3887-901. 477 
33. Joseph B, Mertins S, Stoll R, Schar J, Umesha KR, Luo Q, et al. Glycerol metabolism and 478 
PrfA activity in Listeria monocytogenes. J Bacteriol 2008; 190:5412-30. 479 
34. Chatterjee SS, Hossain H, Otten S, Kuenne C, Kuchmina K, Machata S, et al. Intracellular 480 
gene expression profile of Listeria monocytogenes. Infect Immun 2006; 74:1323-38. 481 
35. Schultze T, Hilker R, Mannala GK, Gentil K, Weigel M, Farmani N, et al. A detailed view 482 
of the intracellular transcriptome of Listeria monocytogenes in murine macrophages using 483 
RNA-seq. Front Microbiol 2015; 6:1199. 484 
  Pinheiro et al 
 
 
 
19
36. Toledo-Arana A, Dussurget O, Nikitas G, Sesto N, Guet-Revillet H, Balestrino D, et al. 485 
The Listeria transcriptional landscape from saprophytism to virulence. Nature 2009; 459:950-486 
6. 487 
37. Camejo A, Buchrieser C, Couve E, Carvalho F, Reis O, Ferreira P, et al. In vivo 488 
transcriptional profiling of Listeria monocytogenes and mutagenesis identify new virulence 489 
factors involved in infection. PLoS Pathog 2009; 5:e1000449. 490 
38. Renier S, Micheau P, Talon R, Hebraud M, Desvaux M. Subcellular Localization of 491 
Extracytoplasmic Proteins in Monoderm Bacteria: Rational Secretomics-Based Strategy for 492 
Genomic and Proteomic Analyses. PLoS One 2012; 7:e42982. 493 
39. Aguilo JI, Alonso H, Uranga S, Marinova D, Arbues A, de Martino A, et al. ESX-1-494 
induced apoptosis is involved in cell-to-cell spread of Mycobacterium tuberculosis. Cell 495 
Microbiol 2013; 15:1994-2005. 496 
40. Walsh D, Sheridan JJ, Duffy G, Blair IS, McDowell DA, Harrington D. Thermal 497 
resistance of wild-type and antibiotic-resistant Listeria monocytogenes in meat and potato 498 
substrates. J Appl Microbiol 2001; 90:555-60. 499 
41. Soni DK, Singh RK, Singh DV, Dubey SK. Characterization of Listeria monocytogenes 500 
isolated from Ganges water, human clinical and milk samples at Varanasi, India. Infect Genet 501 
Evol 2013; 14:83-91. 502 
42. Glaser P, Frangeul L, Buchrieser C, Rusniok C, Amend A, Baquero F, et al. Comparative 503 
genomics of Listeria species. Science 2001; 294:849-52. 504 
43. Becavin C, Bouchier C, Lechat P, Archambaud C, Creno S, Gouin E, et al. Comparison of 505 
widely used Listeria monocytogenes strains EGD, 10403S, and EGD-e highlights genomic 506 
variations underlying differences in pathogenicity. MBio 2014; 5:e00969-14. 507 
44. Tsai HN, Hodgson DA. Development of a synthetic minimal medium for Listeria 508 
monocytogenes. Appl Environ Microbiol 2003; 69:6943-5. 509 
45. Reis O, Sousa S, Camejo A, Villiers V, Gouin E, Cossart P, et al. LapB, a novel Listeria 510 
monocytogenes LPXTG surface adhesin, required for entry into eukaryotic cells and virulence. 511 
J Infect Dis 2010; 202:551-62. 512 
46. Lecuit M, Ohayon H, Braun L, Mengaud J, Cossart P. Internalin of Listeria 513 
monocytogenes with an intact leucine-rich repeat region is sufficient to promote internalization. 514 
Infect Immun 1997; 65:5309-19. 515 
47. Garcia-del Portillo F, Calvo E, D'Orazio V, Pucciarelli MG. Association of ActA to 516 
peptidoglycan revealed by cell wall proteomics of intracellular Listeria monocytogenes. J Biol 517 
Chem 2011; 286:34675-89. 518 
48. Milohanic E, Glaser P, Coppee JY, Frangeul L, Vega Y, Vazquez-Boland JA, et al. 519 
Transcriptome analysis of Listeria monocytogenes identifies three groups of genes differently 520 
regulated by PrfA. Mol Microbiol 2003; 47:1613-25. 521 
49. Cabanes D, Lecuit M, Cossart P. Animal models of Listeria infection. Curr Protoc 522 
Microbiol 2008; Chapter 9:Unit9B 1. 523 
 524 
525 
  Pinheiro et al 
 
 
 
20
Figure Legends 526 
 527 
Figure 1 528 
The ESX-1 locus. (A) Comparison of ESX-1 loci of M. tuberculosis, S. aureus, L. 529 
monocytogenes EGDe, and other Listeria species as indicated. Protein homology percentages 530 
relative to L. monocytogenes EGDe are indicated under each corresponding encoding gene. (B) 531 
Schematic representation showing membrane topology or soluble character of proteins encoded 532 
by the L. monocytogenes, S. aureus and M. tuberculosis ESX-1 locus. (A and B) Genes and 533 
proteins are coloured following the same code: red corresponds to WXG100 encoding genes or 534 
proteins predicted to be secreted to the extracellular medium; blue indicates genes predicted as 535 
encoding soluble cytoplasmic proteins; yellow is related to genes or proteins predicted as 536 
transmembrane proteins.  537 
 538 
Figure 2 539 
Lm ESX-1 system is weakly expressed but functional. (A) Expression of ESX-1 genes in 540 
standard growth conditions. The expression of esxA, esxB, essC and essB was analysed by RT-541 
PCR on total RNAs extracted from logarithmic cultures grown in BHI at 37°C. inlA, actA and 542 
iap were used as control genes. (B) Expression of esxA at exponential (Exp) and stationary 543 
(Stat) phase of growth measured by RT-PCR (left panel) and qRT-PCR (right panel). 544 
Expression value in stationary phase is expressed relative to the value obtained in exponential 545 
growth phase. (C) SigB-independent expression of esxA. qRT-PCRs performed on total RNAs 546 
extracted from WT and ∆sigB strains at the exponential (left panel) and stationary (right panel) 547 
phase of growth in BHI at 37°C. bsh was used as control gene whose expression is SigB-548 
dependent. Gene expression levels in the ∆sigB mutant were normalized to those in the WT. (B 549 
and C) Values are mean ± SD (n=3). (D) Secretion of EsxA is dependent on EssC. Detection of 550 
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myc-tagged EsxA protein (EsxA-myc) in supernatants of Lm EGDe+esxA-myc (WT+ esxA-551 
myc) at different stage of growth (OD600nm = 0.7, 1.4 and 1.8) (Left panel), and in total bacterial 552 
lysates and supernatants from WT, WT+esxA-myc, ΔessC, ΔessC+esxA-myc and 553 
ΔessC+essC+esxA-myc strains in exponential growth phase (Right panel). 554 
 555 
Figure 3 556 
The Lm ESX-1 secretion system is dispensable for epithelial cell invasion and intracellular 557 
multiplication in macrophages. (A) Entry of the WT, ΔesxA, ΔesxB and ΔessC into Caco-2 and 558 
Vero cell lines. Values are expressed relative to WT values arbitrarily fixed to 100%. (B) 559 
Intracellular replication behaviour of the WT, ΔesxA, ΔesxB and ΔessC strains in J774 cells. 560 
Values are mean ± SD (n=3). 561 
 562 
Figure 4 563 
Lm ESX-1 secretion system is detrimental for in vivo infection.  Bacterial counts for the WT, 564 
ΔesxA, ΔesxB and ΔessC strains, in spleens and livers of BALB/c mice (n=5), 72h after (A) 565 
intravenous infection with 104 bacteria or (B) oral infection with 109 bacteria. Data are 566 
presented as scatter plots, which each animal represented by a dot and the mean is indicated by 567 
a horizontal line. *, p≤0.05. 568 
 569 
Figure 5 570 
EsxA secretion impairs Lm infection in vivo through an IFN-γ-independent mechanism.  (A) 571 
Bacterial counts for WT, ΔesxA and +esxA strains, in spleens and livers of BALB/c mice (n=5), 572 
72h after intravenous infection with 104 bacteria. (B) Bacterial counts for WT and ΔessC+esxA 573 
strains, in spleens and livers of BALB/c mice (n=5), 72h after intravenous infection with 104 574 
bacteria. (C) Levels of IFN-γ and TNF-α transcripts measured by qRT-PCR in livers of mice 575 
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72h after intravenous infection with either WT or +esxA bacteria. Expression levels in +esxA-576 
infected livers were normalized to those infected with the WT strain. Values are mean ± SD 577 
(n=3). (D) Bacterial counts for WT and +esxA strains in spleens and livers of WT and IFN-γ 578 
knock-out mice (n=5), 72h after intravenous infection with 104 bacteria. *, p≤0.05; **, p≤0.01. 579 
 580 
Figure S1 581 
(A) Genotype confirmation of esxA, esxB and essC deletion mutant and corresponding 582 
complemented strains by PCR. (B) Growth curves of WT, ΔesxA, ΔesxB, ΔesxB+esxB, ΔessC 583 
and ΔessC+essC strains at 37ºC in BHI broth. (C) Growth curves of WT and ΔessC strains at 584 
37ºC in BHI broth with pH adjusted to 5.5 or supplemented with 4.5% NaCl. 585 
 586 
Figure S2 587 
Phenotypic analysis of the Lm strain overexpressing esxA (+esxA). (A) The expression level of 588 
esxA in the +esxA strain was measured by qRT-PCR and is shown relative to its level in WT 589 
strain. Values are mean ± SD (n=3).  (B) Growth curves of the WT and +esxA strains at 37ºC 590 
in BHI broth and minimal medium. (C) Caco-2 cell adhesion and invasion by the WT and 591 
+esxA strains. Values are mean ± SD (n=3) and are expressed as percentage relative to WT 592 
values arbitrarily fixed to 100%. 593 
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Table S1 - Oligonucleotides 
Name Sequence (5’ > 3’) 
lmo0063-A atgtggatcctgaactaattggtcagaatatgg 
lmo0063-B gattacgcgttctttagcctctcctctcgttc 
lmo0063-C ttacgcgtcagtggaaacgatagacgtattttca 
lmo0063-D caagagatcttcatagtcttttcacatccttgg 
lmo0056-A cggatcccgctttagatgatgg 
lmo0056-B gtacgcgtcattcacttcatcacc 
lmo0056-C cgacgcgttaaaatcaacaaaaagtgg 
lmo0056-D cagagatctaagttttctgtgaattctgc 
lmo0061-A caggtcgacacaagttcgaaaaatgggacg 
lmo0061-B agacgcgtggtccattctcccttattttgc 
lmo0061-C cgacgcgttgaaaggagctgttaatgatgg 
lmo0061-D ggaattctcattgggtgttttttctag 
lmo0056-RT-PCR Fw ggtcaaattcgtatgagtcca 
lmo0056-RT-PCR Rv atcgtgctcttctactgcgtttgc 
lmo0058-RT-PCR Fw gggagttctcgctgcggattcag 
lmo0058-RT-PCR Rv aagtgagtctttaatccggtca 
lmo0060-RT-PCR Fw cttgtacaatggctcgctatcagg 
lmo0060-RT-PCR Rv agcgacgataatgaaaccaaccg 
lmo0061-RT-PCR Fw tgggcatttagctgtgttttctagtc 
lmo0061-RT-PCR Rv attctagtgttaagcgacgaataag 
lmo0063-RT-PCR Fw ggtaatgtgaaaattgatgccgc 
lmo0063-RT-PCR Rv gagtatgaagtattctcaaaatcc 
 
